Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles

por Ilyinskii, Petr O., Roy, Christopher J., LePrevost, Julie, Rizzo, Gina L., Kishimoto, Takashi Kei
Publicado 2021

Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents

por Ilyinskii, Petr O, Roy, Christopher, Michaud, Alicia, Rizzo, Gina, Capela, Teresa, Leung, Sheldon S, Kishimoto, Takashi Kei
Publicado 2023

Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles

por Ilyinskii, Petr O., Michaud, Alicia M., Roy, Christopher J., Rizzo, Gina L., Elkins, Stephanie L., Capela, Teresa, Chowdhury, Aparajita C., Leung, Sheldon S., Kishimoto, Takashi K.
Publicado 2021

ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia

por Ilyinskii, Petr O., Michaud, Alicia M., Rizzo, Gina L., Roy, Christopher J., Leung, Sheldon S., Elkins, Stephanie L., Capela, Teresa, Chowdhury, Aparajita, Li, Lina, Chandler, Randy J., Manoli, Irini, Andres-Mateos, Eva, Johnston, Lloyd P.M., Vandenberghe, Luk H., Venditti, Charles P., Kishimoto, Takashi Kei
Publicado 2021